Gilead – Introduction
Gilead discovers, develops, and commercializes treatments for infectious and pulmonary diseases. The company’s late stage products and those already on the market have significant upside potential in terms of sales volume and market share, as well as geographic expansion. The company enjoys dominant positions in its relevant areas of expertise.
Link to the biotechnology report
Gilead
01/02/2014
